Staphylokinase — a new approach in the treatment of vascular disease
Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
Staphylokinase is a new promising therapeutic agent with an expanding clinical applicationin the treatment of vascular disease. In the present paper the authors discuss the biochemicaland physiological properties of the recombinant protein. The methods and techniques of proteinsynthesis, isolation and purification, including the genetic engineering approaches are criticallysummarized. The emphasis is put onto the critical review of the experiments concerning theuse of staphylokinase in thrombotic models in experimental animals. Moreover, we discuss thepotential role and advantages of staphylokinase over the other thrombolytic agents in the treatment of cardiovascular disease in humans
Biotechnologia, vol.34, 3 (1996)-.
0860-7796 ; oai:rcin.org.pl:146809 ; IChB B-30
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
Nov 10, 2020
Nov 10, 2020
411
https://rcin.org.pl./publication/182456
Edition name | Date |
---|---|
Stafylokinaza — nowy środek w leczeniu chorób układu krążenia | Nov 10, 2020 |
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan